Operating Lease, Right-of-Use Asset in USD of GALECTIN THERAPEUTICS INC from Q3 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GALECTIN THERAPEUTICS INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q3 2021 to Q3 2025.
  • GALECTIN THERAPEUTICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $37K, a 42.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GALECTIN THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $37K +$11K +42.3% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $52K +$17K +48.6% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $66K +$21K +46.7% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $16K -$30K -65.2% 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $26K -$36K -58.1% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $35K -$35K -50% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $45K -$33K -42.3% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $46K -$40K -46.5% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $62K -$31K -33.3% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $70K -$31K -30.7% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $78K -$30K -27.8% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $86K +$79K +1129% 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 $93K +$75K +417% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $101K 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $108K 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $7K 31 Dec 2021 10-K 31 Mar 2022
Q3 2021 $18K 30 Sep 2021 10-Q 15 Nov 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.